![Christian C. Fritz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Dr. Christian C.
Fritz is Vice President-Biology at Syros Pharmaceuticals, Inc.
Dr. Fritz was previously employed as a Principal by Max-Planck Institute of Psychiatry, Senior Director-Cancer Cell Biology by Infinity Pharmaceuticals, Inc., and Senior Scientist by Millennium Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Hannover and a doctorate degree from Universität zu Köln.
Anciens postes connus de Christian C. Fritz
Sociétés | Poste | Fin |
---|---|---|
SYROS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2017 |
Max-Planck Institute of Psychiatry | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Christian C. Fritz
Universität zu Köln | Doctorate Degree |
University of Hannover | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
INFINITY PHARMACEUTICALS, INC. | Health Technology |
SYROS PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Max-Planck Institute of Psychiatry |